Deborah Dobrez

Quality of Life in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia on Imatinib Versus Interferon Alfa Plus Low-Dose Cytarabine: Results From the IRIS Study

Elizabeth A. Hahn, G. Alastair Glendenning, Mark Sorensen et al. · Journal of Clinical Oncology · 2003 · 208 citations

Estimating the Cost of Developmental and Behavioral Screening of Preschool Children in General Pediatric Practice

Deborah Dobrez, Anthony Lo Sasso, Jane L. Holl et al. · PEDIATRICS · 2001 · 89 citations

The talking touchscreen: A new approach to outcomes assessment in low literacy

Elizabeth A. Hahn, David Cella, Deborah Dobrez et al. · Psycho-Oncology · 2003 · 87 citations

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

Gershon Y. Locker, Robert E. Mansel, David Cella et al. · Breast Cancer Research and Treatment · 2007 · 74 citations

Breast Oncology, Cost-effectiveness Analysis, Medicine +10

Estimation of Patient Preference-Based Utility Weights from the Functional Assessment of Cancer Therapy—General

Deborah Dobrez, David Cella, A. Simon Pickard et al. · Value in Health · 2007 · 66 citations · Full text

Functional Assessment, Health Policy, Medicine +8